| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | 4.10e-10 | 303 | 30 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription factor binding | 8.30e-08 | 753 | 30 | 10 | GO:0008134 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 8.77e-08 | 562 | 30 | 9 | GO:0003712 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 1.24e-06 | 54 | 30 | 4 | GO:0001223 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 2.18e-06 | 2 | 30 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 2.18e-06 | 2 | 30 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 4.00e-06 | 21 | 30 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TRERF1 SMARCA2 KMT2C NCOA6 TSC22D1 TCF20 CREBBP YAP1 EP300 TNRC6A | 4.34e-06 | 1160 | 30 | 10 | GO:0030674 |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 6.54e-06 | 3 | 30 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 8.05e-06 | 187 | 30 | 5 | GO:0016922 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | TRERF1 SMARCA2 KMT2C NCOA6 TSC22D1 TCF20 CREBBP YAP1 EP300 TNRC6A | 1.73e-05 | 1356 | 30 | 10 | GO:0060090 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.96e-05 | 582 | 30 | 7 | GO:0140297 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 2.30e-05 | 37 | 30 | 3 | GO:0043425 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 3.11e-05 | 417 | 30 | 6 | GO:0061629 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 5.51e-05 | 140 | 30 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 6.07e-05 | 51 | 30 | 3 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 7.62e-05 | 55 | 30 | 3 | GO:0061733 | |
| GeneOntologyMolecularFunction | chromatin binding | 8.93e-05 | 739 | 30 | 7 | GO:0003682 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 9.88e-05 | 60 | 30 | 3 | GO:0034212 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 2.16e-04 | 78 | 30 | 3 | GO:0008080 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 2.26e-04 | 15 | 30 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 2.69e-04 | 84 | 30 | 3 | GO:0003684 | |
| GeneOntologyMolecularFunction | histone modifying activity | 3.65e-04 | 229 | 30 | 4 | GO:0140993 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 4.08e-04 | 20 | 30 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 4.75e-04 | 102 | 30 | 3 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 5.03e-04 | 104 | 30 | 3 | GO:0016407 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 5.41e-04 | 23 | 30 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1.09e-03 | 1459 | 30 | 8 | GO:0000977 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 1.98e-03 | 167 | 30 | 3 | GO:0031490 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 2.87e-03 | 53 | 30 | 2 | GO:0030331 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 3.08e-03 | 55 | 30 | 2 | GO:0042974 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 3.78e-03 | 61 | 30 | 2 | GO:0030374 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 4.81e-03 | 229 | 30 | 3 | GO:0003714 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 5.35e-03 | 238 | 30 | 3 | GO:0016747 | |
| GeneOntologyMolecularFunction | p53 binding | 5.95e-03 | 77 | 30 | 2 | GO:0002039 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 6.89e-03 | 83 | 30 | 2 | GO:1990841 | |
| GeneOntologyMolecularFunction | SMAD binding | 7.37e-03 | 86 | 30 | 2 | GO:0046332 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 9.15e-03 | 875 | 30 | 5 | GO:0019904 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 9.43e-03 | 1244 | 30 | 6 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 1.04e-02 | 1271 | 30 | 6 | GO:0000987 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.55e-02 | 127 | 30 | 2 | GO:0008094 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 1.68e-02 | 363 | 30 | 3 | GO:0106310 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | MED25 TRERF1 SMARCA2 BPTF KMT2C NCOA6 TSC22D1 ISL1 OTX2 TCF20 CLOCK CREBBP YAP1 EP300 ARID2 | 1.48e-10 | 1390 | 30 | 15 | GO:0045944 |
| GeneOntologyBiologicalProcess | head development | 3.91e-07 | 919 | 30 | 10 | GO:0060322 | |
| GeneOntologyBiologicalProcess | regulation of cell development | SMARCA2 PAK3 MACF1 OTP TSC22D1 DIXDC1 CLOCK YAP1 EP300 ARID2 | 1.93e-06 | 1095 | 30 | 10 | GO:0060284 |
| GeneOntologyBiologicalProcess | stimulatory C-type lectin receptor signaling pathway | 4.82e-06 | 23 | 30 | 3 | GO:0002223 | |
| GeneOntologyBiologicalProcess | cellular response to lectin | 4.82e-06 | 23 | 30 | 3 | GO:1990858 | |
| GeneOntologyBiologicalProcess | response to lectin | 4.82e-06 | 23 | 30 | 3 | GO:1990840 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 7.75e-06 | 741 | 30 | 8 | GO:0006338 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 8.05e-06 | 999 | 30 | 9 | GO:0071824 | |
| GeneOntologyBiologicalProcess | cellular response to radiation | 8.23e-06 | 194 | 30 | 5 | GO:0071478 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 1.22e-05 | 4 | 30 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 1.71e-05 | 1399 | 30 | 10 | GO:0045892 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 1.76e-05 | 35 | 30 | 3 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 1.76e-05 | 35 | 30 | 3 | GO:0030511 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 1.86e-05 | 1413 | 30 | 10 | GO:1902679 | |
| GeneOntologyBiologicalProcess | embryo development | 2.16e-05 | 1437 | 30 | 10 | GO:0009790 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 2.24e-05 | 614 | 30 | 7 | GO:0010720 | |
| GeneOntologyBiologicalProcess | brain development | 2.26e-05 | 859 | 30 | 8 | GO:0007420 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 2.34e-05 | 1141 | 30 | 9 | GO:0045597 | |
| GeneOntologyBiologicalProcess | chromatin organization | 3.07e-05 | 896 | 30 | 8 | GO:0006325 | |
| GeneOntologyBiologicalProcess | central nervous system development | 3.41e-05 | 1197 | 30 | 9 | GO:0007417 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 4.34e-05 | 136 | 30 | 4 | GO:0030518 | |
| GeneOntologyBiologicalProcess | DNA damage response | 4.97e-05 | 959 | 30 | 8 | GO:0006974 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 5.52e-05 | 51 | 30 | 3 | GO:1902459 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 7.22e-05 | 155 | 30 | 4 | GO:0043401 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 8.39e-05 | 515 | 30 | 6 | GO:0050767 | |
| GeneOntologyBiologicalProcess | columnar/cuboidal epithelial cell differentiation | 8.99e-05 | 164 | 30 | 4 | GO:0002065 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 9.61e-05 | 1053 | 30 | 8 | GO:0000122 | |
| GeneOntologyBiologicalProcess | regulation of protein localization | 1.20e-04 | 1087 | 30 | 8 | GO:0032880 | |
| GeneOntologyBiologicalProcess | protein acetylation | 1.31e-04 | 68 | 30 | 3 | GO:0006473 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.41e-04 | 566 | 30 | 6 | GO:0007409 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 1.45e-04 | 354 | 30 | 5 | GO:0050769 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 1.65e-04 | 192 | 30 | 4 | GO:0050770 | |
| GeneOntologyBiologicalProcess | cellular response to abiotic stimulus | 1.80e-04 | 371 | 30 | 5 | GO:0071214 | |
| GeneOntologyBiologicalProcess | cellular response to environmental stimulus | 1.80e-04 | 371 | 30 | 5 | GO:0104004 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 1.96e-04 | 78 | 30 | 3 | GO:2000036 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 2.00e-04 | 202 | 30 | 4 | GO:0141193 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 2.04e-04 | 381 | 30 | 5 | GO:0048545 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 2.41e-04 | 625 | 30 | 6 | GO:0051960 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid acetylation | 2.42e-04 | 16 | 30 | 2 | GO:0006474 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 2.42e-04 | 16 | 30 | 2 | GO:1900034 | |
| GeneOntologyBiologicalProcess | regulation of G1/S transition of mitotic cell cycle | 2.45e-04 | 213 | 30 | 4 | GO:2000045 | |
| GeneOntologyBiologicalProcess | regulation of cellular localization | 2.54e-04 | 1212 | 30 | 8 | GO:0060341 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 2.71e-04 | 87 | 30 | 3 | GO:0033143 | |
| GeneOntologyBiologicalProcess | axon development | 2.79e-04 | 642 | 30 | 6 | GO:0061564 | |
| GeneOntologyBiologicalProcess | endoderm development | 2.80e-04 | 88 | 30 | 3 | GO:0007492 | |
| GeneOntologyBiologicalProcess | diencephalon development | 2.99e-04 | 90 | 30 | 3 | GO:0021536 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 3.13e-04 | 418 | 30 | 5 | GO:0051962 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 3.51e-04 | 95 | 30 | 3 | GO:2000781 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 3.68e-04 | 237 | 30 | 4 | GO:0019827 | |
| GeneOntologyBiologicalProcess | cellular response to UV | 3.73e-04 | 97 | 30 | 3 | GO:0034644 | |
| GeneOntologyBiologicalProcess | neuron projection development | 3.78e-04 | 1285 | 30 | 8 | GO:0031175 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 3.80e-04 | 239 | 30 | 4 | GO:0071383 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 3.99e-04 | 242 | 30 | 4 | GO:0098727 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 4.11e-04 | 244 | 30 | 4 | GO:0009755 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | 4.24e-04 | 246 | 30 | 4 | GO:1902806 | |
| GeneOntologyBiologicalProcess | regulation of smoothened signaling pathway | 4.71e-04 | 105 | 30 | 3 | GO:0008589 | |
| GeneOntologyBiologicalProcess | innate immune response activating cell surface receptor signaling pathway | 4.98e-04 | 107 | 30 | 3 | GO:0002220 | |
| GeneOntologyBiologicalProcess | protein acylation | 5.11e-04 | 108 | 30 | 3 | GO:0043543 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 5.99e-04 | 114 | 30 | 3 | GO:0050772 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to nucleus | 5.99e-04 | 114 | 30 | 3 | GO:1900182 | |
| GeneOntologyBiologicalProcess | G1/S transition of mitotic cell cycle | 6.10e-04 | 271 | 30 | 4 | GO:0000082 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 6.14e-04 | 115 | 30 | 3 | GO:0090100 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 6.23e-04 | 1048 | 30 | 7 | GO:0014070 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 6.28e-04 | 748 | 30 | 6 | GO:0048667 | |
| GeneOntologyBiologicalProcess | heart development | 6.69e-04 | 757 | 30 | 6 | GO:0007507 | |
| GeneOntologyBiologicalProcess | response to radiation | 7.28e-04 | 503 | 30 | 5 | GO:0009314 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine acetylation | 7.55e-04 | 28 | 30 | 2 | GO:0018394 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 8.10e-04 | 29 | 30 | 2 | GO:2000819 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid modification | 8.10e-04 | 29 | 30 | 2 | GO:0031365 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | 8.16e-04 | 516 | 30 | 5 | GO:1901987 | |
| GeneOntologyBiologicalProcess | cellular response to light stimulus | 8.77e-04 | 130 | 30 | 3 | GO:0071482 | |
| GeneOntologyBiologicalProcess | neuron development | 8.98e-04 | 1463 | 30 | 8 | GO:0048666 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 9.05e-04 | 802 | 30 | 6 | GO:0048812 | |
| GeneOntologyBiologicalProcess | cell cycle G1/S phase transition | 9.60e-04 | 306 | 30 | 4 | GO:0044843 | |
| GeneOntologyBiologicalProcess | regulation of fibroblast proliferation | 9.78e-04 | 135 | 30 | 3 | GO:0048145 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 9.99e-04 | 136 | 30 | 3 | GO:0045445 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 1.01e-03 | 819 | 30 | 6 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue growth | 1.04e-03 | 138 | 30 | 3 | GO:0055017 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 1.05e-03 | 826 | 30 | 6 | GO:0048858 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 1.15e-03 | 143 | 30 | 3 | GO:0045739 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 1.18e-03 | 144 | 30 | 3 | GO:0045582 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 1.19e-03 | 561 | 30 | 5 | GO:0048568 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 1.23e-03 | 146 | 30 | 3 | GO:2000779 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 1.23e-03 | 327 | 30 | 4 | GO:0048738 | |
| GeneOntologyBiologicalProcess | heart growth | 1.28e-03 | 148 | 30 | 3 | GO:0060419 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | 1.31e-03 | 333 | 30 | 4 | GO:0051054 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | 1.32e-03 | 1190 | 30 | 7 | GO:0008284 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 1.34e-03 | 1194 | 30 | 7 | GO:0000902 | |
| GeneOntologyBiologicalProcess | metencephalon development | 1.40e-03 | 153 | 30 | 3 | GO:0022037 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | 1.42e-03 | 875 | 30 | 6 | GO:0045596 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | 1.49e-03 | 591 | 30 | 5 | GO:1903829 | |
| GeneOntologyBiologicalProcess | mesoderm development | 1.51e-03 | 157 | 30 | 3 | GO:0007498 | |
| GeneOntologyBiologicalProcess | positive regulation of Wnt signaling pathway | 1.54e-03 | 158 | 30 | 3 | GO:0030177 | |
| GeneOntologyCellularComponent | transcription regulator complex | 5.92e-09 | 596 | 30 | 10 | GO:0005667 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | MED25 TRERF1 SMARCA2 BPTF KMT2C NCOA6 BICRAL AFF2 SMG7 CLOCK CREBBP YAP1 ARID2 | 1.73e-08 | 1377 | 30 | 13 | GO:0140513 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.04e-05 | 96 | 30 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 1.05e-05 | 30 | 30 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | chromatin | 2.48e-05 | 1480 | 30 | 10 | GO:0000785 | |
| GeneOntologyCellularComponent | ATPase complex | 3.35e-05 | 129 | 30 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 1.30e-04 | 12 | 30 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | GBAF complex | 1.79e-04 | 14 | 30 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 5.89e-04 | 272 | 30 | 4 | GO:0090575 | |
| HumanPheno | Aggressive behavior | MED25 CUL4B SMARCA2 PAK3 BPTF KMT2C TCF20 AFF2 CREBBP EP300 ARID2 | 1.71e-07 | 516 | 18 | 11 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | MED25 CUL4B SMARCA2 PAK3 BPTF KMT2C TCF20 AFF2 CREBBP EP300 ARID2 | 1.71e-07 | 516 | 18 | 11 | HP:0006919 |
| HumanPheno | Clinodactyly | MED25 CUL4B SMARCA2 BPTF SIK3 TCF20 AFF2 CPLANE1 CREBBP EP300 ARID2 | 5.14e-07 | 574 | 18 | 11 | HP:0030084 |
| HumanPheno | Sandal gap | 5.92e-07 | 96 | 18 | 6 | HP:0001852 | |
| HumanPheno | Epicanthus | MED25 CUL4B SMARCA2 BPTF MACF1 TCF20 AFF2 CPLANE1 CREBBP EP300 ARID2 | 1.03e-06 | 614 | 18 | 11 | HP:0000286 |
| HumanPheno | Abnormal upper lip morphology | MED25 CUL4B SMARCA2 PAK3 BPTF OTX2 TCF20 AFF2 CPLANE1 CREBBP YAP1 EP300 ARID2 | 1.51e-06 | 980 | 18 | 13 | HP:0000177 |
| HumanPheno | Abnormal 5th finger morphology | CUL4B SMARCA2 BPTF SIK3 TCF20 AFF2 CPLANE1 CREBBP EP300 ARID2 | 1.90e-06 | 509 | 18 | 10 | HP:0004207 |
| HumanPheno | Abnormal lip morphology | MED25 CUL4B SMARCA2 PAK3 BPTF KMT2C OTX2 TCF20 AFF2 CPLANE1 CREBBP YAP1 EP300 ARID2 | 2.94e-06 | 1249 | 18 | 14 | HP:0000159 |
| HumanPheno | Deviation of finger | MED25 CUL4B SMARCA2 BPTF SIK3 TCF20 AFF2 CPLANE1 CREBBP EP300 | 3.12e-06 | 537 | 18 | 10 | HP:0004097 |
| HumanPheno | Abnormal pinna morphology | MED25 CUL4B SMARCA2 PAK3 BPTF MACF1 KMT2C OTX2 TCF20 AFF2 CPLANE1 CREBBP EP300 ARID2 | 4.87e-06 | 1299 | 18 | 14 | HP:0000377 |
| HumanPheno | Deviation of the hand or of fingers of the hand | MED25 CUL4B SMARCA2 BPTF SIK3 TCF20 AFF2 CPLANE1 CREBBP EP300 | 4.91e-06 | 564 | 18 | 10 | HP:0009484 |
| HumanPheno | Radial deviation of finger | 6.88e-06 | 448 | 18 | 9 | HP:0009466 | |
| HumanPheno | Abnormality of the outer ear | MED25 CUL4B SMARCA2 PAK3 BPTF MACF1 KMT2C OTX2 TCF20 AFF2 CPLANE1 CREBBP EP300 ARID2 | 7.05e-06 | 1337 | 18 | 14 | HP:0000356 |
| HumanPheno | Finger clinodactyly | 7.41e-06 | 452 | 18 | 9 | HP:0040019 | |
| HumanPheno | Delayed speech and language development | MED25 CUL4B SMARCA2 PAK3 BPTF MACF1 KMT2C SIK3 TCF20 AFF2 CREBBP EP300 ARID2 | 7.61e-06 | 1123 | 18 | 13 | HP:0000750 |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | 7.97e-06 | 456 | 18 | 9 | HP:0009485 | |
| HumanPheno | Poor coordination | 8.31e-06 | 39 | 18 | 4 | HP:0002370 | |
| HumanPheno | Thick eyebrow | 9.52e-06 | 154 | 18 | 6 | HP:0000574 | |
| HumanPheno | Plantar crease between first and second toes | 1.18e-05 | 2 | 18 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 1.18e-05 | 2 | 18 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 1.18e-05 | 2 | 18 | 2 | HP:0001042 | |
| HumanPheno | Language impairment | MED25 CUL4B SMARCA2 PAK3 BPTF MACF1 KMT2C SIK3 TCF20 AFF2 CREBBP EP300 ARID2 | 1.33e-05 | 1178 | 18 | 13 | HP:0002463 |
| HumanPheno | Disinhibition | MED25 CUL4B SMARCA2 PAK3 BPTF KMT2C TCF20 AFF2 CREBBP EP300 ARID2 | 1.61e-05 | 807 | 18 | 11 | HP:0000734 |
| HumanPheno | Inappropriate behavior | MED25 CUL4B SMARCA2 PAK3 BPTF KMT2C TCF20 AFF2 CREBBP EP300 ARID2 | 1.61e-05 | 807 | 18 | 11 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | MED25 CUL4B SMARCA2 PAK3 BPTF KMT2C TCF20 AFF2 CREBBP EP300 ARID2 | 1.61e-05 | 807 | 18 | 11 | HP:5200123 |
| HumanPheno | Social disinhibition | MED25 CUL4B SMARCA2 PAK3 BPTF KMT2C TCF20 AFF2 CREBBP EP300 ARID2 | 1.61e-05 | 807 | 18 | 11 | HP:5200029 |
| HumanPheno | Reduced impulse control | MED25 CUL4B SMARCA2 PAK3 BPTF KMT2C OTX2 TCF20 AFF2 CREBBP EP300 ARID2 | 2.48e-05 | 1032 | 18 | 12 | HP:5200045 |
| HumanPheno | Abnormal eyebrow morphology | MED25 CUL4B SMARCA2 BPTF KMT2C OTX2 CPLANE1 CREBBP EP300 ARID2 | 2.48e-05 | 674 | 18 | 10 | HP:0000534 |
| HumanPheno | Motor stereotypy | 2.65e-05 | 280 | 18 | 7 | HP:0000733 | |
| HumanPheno | Abnormally increased volition | MED25 CUL4B SMARCA2 PAK3 BPTF KMT2C TCF20 AFF2 CREBBP EP300 ARID2 | 3.33e-05 | 869 | 18 | 11 | HP:5200263 |
| HumanPheno | Laryngeal cartilage malformation | 3.53e-05 | 3 | 18 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 3.53e-05 | 3 | 18 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 3.53e-05 | 3 | 18 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 3.53e-05 | 3 | 18 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 3.53e-05 | 3 | 18 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 3.53e-05 | 3 | 18 | 2 | HP:0005895 | |
| HumanPheno | Recurrent maladaptive behavior | MED25 CUL4B SMARCA2 PAK3 BPTF MACF1 KMT2C OTX2 TCF20 AFF2 CREBBP EP300 ARID2 | 3.94e-05 | 1293 | 18 | 13 | HP:5200241 |
| HumanPheno | Clinodactyly of the 5th finger | 4.17e-05 | 420 | 18 | 8 | HP:0004209 | |
| HumanPheno | Clinodactyly of hands | 4.25e-05 | 421 | 18 | 8 | HP:0001157 | |
| HumanPheno | Deviation of the 5th finger | 4.25e-05 | 421 | 18 | 8 | HP:0009179 | |
| HumanPheno | Abnormal social development | MED25 CUL4B SMARCA2 PAK3 BPTF KMT2C TCF20 AFF2 CREBBP EP300 ARID2 | 5.11e-05 | 908 | 18 | 11 | HP:0025732 |
| HumanPheno | Abnormal external nose morphology | MED25 CUL4B SMARCA2 PAK3 BPTF OTX2 TCF20 CPLANE1 CREBBP EP300 ARID2 | 5.56e-05 | 916 | 18 | 11 | HP:0010938 |
| HumanPheno | Trichiasis | 7.05e-05 | 4 | 18 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 7.05e-05 | 4 | 18 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 7.05e-05 | 4 | 18 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 7.05e-05 | 4 | 18 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 7.05e-05 | 4 | 18 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 7.05e-05 | 4 | 18 | 2 | HP:0031207 | |
| HumanPheno | Abnormal earlobe morphology | 8.45e-05 | 137 | 18 | 5 | HP:0000363 | |
| HumanPheno | Abnormality of upper lip vermillion | 8.58e-05 | 464 | 18 | 8 | HP:0011339 | |
| HumanPheno | Abnormal finger morphology | MED25 CUL4B SMARCA2 PAK3 BPTF KMT2C SIK3 TCF20 AFF2 CPLANE1 CREBBP EP300 ARID2 | 8.66e-05 | 1385 | 18 | 13 | HP:0001167 |
| HumanPheno | Thin upper lip vermilion | 9.11e-05 | 339 | 18 | 7 | HP:0000219 | |
| HumanPheno | Thin lips | 9.11e-05 | 339 | 18 | 7 | HP:0000213 | |
| HumanPheno | Overlapping toe | 9.67e-05 | 72 | 18 | 4 | HP:0001845 | |
| HumanPheno | Constipation | 9.71e-05 | 472 | 18 | 8 | HP:0002019 | |
| HumanPheno | Broad distal phalanx of finger | 1.03e-04 | 27 | 18 | 3 | HP:0009836 | |
| HumanPheno | Short stature | CUL4B SMARCA2 PAK3 BPTF MACF1 KMT2C OTX2 SIK3 AFF2 CPLANE1 CREBBP EP300 ARID2 | 1.04e-04 | 1407 | 18 | 13 | HP:0004322 |
| HumanPheno | Abnormal eyelid morphology | MED25 CUL4B SMARCA2 PAK3 BPTF MACF1 KMT2C TCF20 AFF2 CPLANE1 CREBBP EP300 ARID2 | 1.04e-04 | 1408 | 18 | 13 | HP:0000492 |
| HumanPheno | Delayed gross motor development | 1.11e-04 | 481 | 18 | 8 | HP:0002194 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 1.17e-04 | 5 | 18 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 1.17e-04 | 5 | 18 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 1.17e-04 | 5 | 18 | 2 | HP:0030421 | |
| HumanPheno | Cerebellar malformation | 1.21e-04 | 487 | 18 | 8 | HP:0002438 | |
| HumanPheno | Broad phalanx | 1.22e-04 | 148 | 18 | 5 | HP:0006009 | |
| HumanPheno | Broad phalanges of the hand | 1.22e-04 | 148 | 18 | 5 | HP:0009768 | |
| HumanPheno | Abnormal palate morphology | MED25 CUL4B SMARCA2 PAK3 KMT2C OTX2 SIK3 CPLANE1 CREBBP YAP1 EP300 ARID2 | 1.24e-04 | 1202 | 18 | 12 | HP:0000174 |
| HumanPheno | Broad eyebrow | 1.28e-04 | 29 | 18 | 3 | HP:0011229 | |
| HumanPheno | Toe syndactyly | 1.30e-04 | 244 | 18 | 6 | HP:0001770 | |
| HumanPheno | Preaxial foot polydactyly | 1.42e-04 | 30 | 18 | 3 | HP:0001841 | |
| HumanPheno | Broad finger | 1.47e-04 | 154 | 18 | 5 | HP:0001500 | |
| HumanPheno | Motor delay | CUL4B SMARCA2 PAK3 BPTF MACF1 KMT2C SIK3 TCF20 CREBBP EP300 ARID2 | 1.53e-04 | 1018 | 18 | 11 | HP:0001270 |
| HumanPheno | Restricted or repetitive behaviors or interests | 1.54e-04 | 368 | 18 | 7 | HP:0031432 | |
| HumanPheno | Prominent lips | 1.57e-04 | 156 | 18 | 5 | HP:0000184 | |
| HumanPheno | High, narrow palate | 1.57e-04 | 156 | 18 | 5 | HP:0002705 | |
| HumanPheno | Short philtrum | 1.58e-04 | 253 | 18 | 6 | HP:0000322 | |
| HumanPheno | Broad long bones | 1.62e-04 | 157 | 18 | 5 | HP:0005622 | |
| HumanPheno | Compulsive behaviors | 1.66e-04 | 158 | 18 | 5 | HP:0000722 | |
| HumanPheno | Abnormal nasal bridge morphology | CUL4B SMARCA2 PAK3 BPTF MACF1 TCF20 AFF2 CPLANE1 CREBBP EP300 ARID2 | 1.70e-04 | 1029 | 18 | 11 | HP:0000422 |
| HumanPheno | Large foramen magnum | 1.75e-04 | 6 | 18 | 2 | HP:0002700 | |
| HumanPheno | Perseverative thought | 1.79e-04 | 377 | 18 | 7 | HP:0030223 | |
| HumanPheno | Brachydactyly | 1.79e-04 | 670 | 18 | 9 | HP:0001156 | |
| HumanPheno | Abnormality of globe location or size | MED25 SMARCA2 PAK3 BPTF MACF1 OTX2 SIK3 TCF20 CPLANE1 CREBBP YAP1 EP300 | 1.80e-04 | 1246 | 18 | 12 | HP:0000489 |
| HumanPheno | Short digit | 1.84e-04 | 672 | 18 | 9 | HP:0011927 | |
| HumanPheno | Broad toe | 2.02e-04 | 87 | 18 | 4 | HP:0001837 | |
| HumanPheno | Disordered formal thought process | 2.08e-04 | 386 | 18 | 7 | HP:0025769 | |
| HumanPheno | Abnormal nasal tip morphology | 2.08e-04 | 386 | 18 | 7 | HP:0000436 | |
| HumanPheno | Thin corpus callosum | MED25 CUL4B SMARCA2 MACF1 KMT2C OTX2 CPLANE1 CREBBP EP300 ARID2 | 2.30e-04 | 868 | 18 | 10 | HP:0033725 |
| HumanPheno | Deviated nasal septum | 2.45e-04 | 7 | 18 | 2 | HP:0004411 | |
| HumanPheno | Displacement of the urethral meatus | 2.48e-04 | 397 | 18 | 7 | HP:0100627 | |
| HumanPheno | Abnormal male urethral meatus morphology | 2.55e-04 | 399 | 18 | 7 | HP:0032076 | |
| HumanPheno | Thick vermilion border | 2.71e-04 | 279 | 18 | 6 | HP:0012471 | |
| HumanPheno | Abnormal hand morphology | MED25 CUL4B SMARCA2 BPTF SIK3 TCF20 AFF2 CPLANE1 CREBBP EP300 ARID2 | 2.72e-04 | 1082 | 18 | 11 | HP:0005922 |
| HumanPheno | Abnormal thought pattern | 2.76e-04 | 404 | 18 | 7 | HP:5200269 | |
| HumanPheno | Natal tooth | 2.89e-04 | 38 | 18 | 3 | HP:0000695 | |
| HumanPheno | Hyperactivity | 3.18e-04 | 558 | 18 | 8 | HP:0000752 | |
| HumanPheno | Abnormal cerebral white matter morphology | MED25 CUL4B SMARCA2 BPTF MACF1 KMT2C OTX2 CPLANE1 CREBBP EP300 ARID2 | 3.58e-04 | 1114 | 18 | 11 | HP:0002500 |
| HumanPheno | Abnormality of mouth size | 3.78e-04 | 425 | 18 | 7 | HP:0011337 | |
| HumanPheno | Frontal bossing | 3.81e-04 | 738 | 18 | 9 | HP:0002007 | |
| HumanPheno | Abnormality of globe location | MED25 SMARCA2 PAK3 BPTF MACF1 OTX2 SIK3 TCF20 CPLANE1 CREBBP EP300 | 3.82e-04 | 1122 | 18 | 11 | HP:0100886 |
| HumanPheno | Abnormal size of the palpebral fissures | 3.89e-04 | 298 | 18 | 6 | HP:0200007 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | CUL4B BPTF NCOA6 BICRAL ISL1 OTX2 CREBBP YAP1 EP300 ARID2 TNRC6A | 2.87e-08 | 700 | 27 | 11 | MP:0011098 |
| MousePheno | embryonic lethality during organogenesis | CUL4B BPTF NCOA6 BICRAL ISL1 OTX2 CREBBP YAP1 EP300 ARID2 TNRC6A | 2.83e-07 | 876 | 27 | 11 | MP:0006207 |
| MousePheno | thin myocardium compact layer | 1.70e-06 | 46 | 27 | 4 | MP:0004057 | |
| MousePheno | abnormal myocardium compact layer morphology | 7.78e-06 | 67 | 27 | 4 | MP:0004056 | |
| MousePheno | prenatal growth retardation | 2.25e-05 | 869 | 27 | 9 | MP:0010865 | |
| MousePheno | abnormal embryo development | CUL4B BPTF MACF1 NCOA6 BICRAL ISL1 OTX2 CPLANE1 CREBBP YAP1 EP300 | 2.28e-05 | 1370 | 27 | 11 | MP:0001672 |
| MousePheno | decreased embryo size | 2.34e-05 | 659 | 27 | 8 | MP:0001698 | |
| MousePheno | embryonic growth arrest | 4.20e-05 | 346 | 27 | 6 | MP:0001730 | |
| MousePheno | abnormal visceral yolk sac mesenchyme morphology | 4.40e-05 | 36 | 27 | 3 | MP:0020516 | |
| MousePheno | abnormal prenatal growth/weight/body size | CUL4B BPTF NCOA6 BICRAL ISL1 OTX2 TCF20 CPLANE1 CREBBP YAP1 EP300 | 5.11e-05 | 1493 | 27 | 11 | MP:0004196 |
| MousePheno | abnormal retina morphology | 5.49e-05 | 1227 | 27 | 10 | MP:0001325 | |
| MousePheno | embryonic growth retardation | 6.66e-05 | 763 | 27 | 8 | MP:0003984 | |
| MousePheno | abnormal ocular fundus morphology | 6.98e-05 | 1262 | 27 | 10 | MP:0002864 | |
| MousePheno | abnormal visceral yolk sac morphology | 7.83e-05 | 236 | 27 | 5 | MP:0001718 | |
| MousePheno | abnormal embryonic growth/weight/body size | 8.70e-05 | 1295 | 27 | 10 | MP:0002088 | |
| MousePheno | abnormal mesoderm morphology | 9.70e-05 | 127 | 27 | 4 | MP:0014141 | |
| MousePheno | abnormal primitive streak elongation | 1.95e-04 | 11 | 27 | 2 | MP:0012685 | |
| MousePheno | abnormal extraembryonic tissue morphology | 2.25e-04 | 908 | 27 | 8 | MP:0002086 | |
| MousePheno | abnormal circadian sleep/wake cycle | 2.34e-04 | 12 | 27 | 2 | MP:0020478 | |
| MousePheno | abnormal germ layer morphology | 2.42e-04 | 161 | 27 | 4 | MP:0014138 | |
| MousePheno | abnormal sleep duration | 2.77e-04 | 13 | 27 | 2 | MP:0021198 | |
| MousePheno | abnormal embryo size | 3.20e-04 | 956 | 27 | 8 | MP:0001697 | |
| MousePheno | small heart | 3.30e-04 | 321 | 27 | 5 | MP:0002188 | |
| MousePheno | ventricle myocardium hypoplasia | 3.36e-04 | 71 | 27 | 3 | MP:0010502 | |
| MousePheno | embryonic-extraembryonic boundary constriction | 3.71e-04 | 15 | 27 | 2 | MP:0012135 | |
| MousePheno | decreased cell proliferation | 3.93e-04 | 739 | 27 | 7 | MP:0000352 | |
| MousePheno | large fontanelles | 4.24e-04 | 16 | 27 | 2 | MP:0030388 | |
| MousePheno | abnormal third ventricle morphology | 4.44e-04 | 78 | 27 | 3 | MP:0000826 | |
| MousePheno | absent olfactory bulb | 4.80e-04 | 17 | 27 | 2 | MP:0003451 | |
| MousePheno | abnormal epicardium morphology | 4.80e-04 | 17 | 27 | 2 | MP:0003057 | |
| MousePheno | abnormal vascular development | 4.88e-04 | 542 | 27 | 6 | MP:0000259 | |
| MousePheno | decreased effector memory T-helper cell number | 5.39e-04 | 18 | 27 | 2 | MP:0013771 | |
| MousePheno | decreased fetal cardiomyocyte proliferation | 5.39e-04 | 18 | 27 | 2 | MP:0011395 | |
| MousePheno | abnormal primitive streak morphology | 5.62e-04 | 201 | 27 | 4 | MP:0002231 | |
| MousePheno | myocardium hypoplasia | 5.91e-04 | 86 | 27 | 3 | MP:0010500 | |
| MousePheno | abnormal heart ventricle morphology | 6.01e-04 | 793 | 27 | 7 | MP:0005294 | |
| MousePheno | abnormal pancreas morphology | 6.08e-04 | 367 | 27 | 5 | MP:0001944 | |
| MousePheno | atrial septal defect | 6.32e-04 | 88 | 27 | 3 | MP:0010403 | |
| MousePheno | abnormal cardiovascular development | 6.43e-04 | 802 | 27 | 7 | MP:0002925 | |
| MousePheno | decreased embryonic neuroepithelium thickness | 6.68e-04 | 20 | 27 | 2 | MP:0012703 | |
| MousePheno | thin ventricle myocardium compact layer | 6.68e-04 | 20 | 27 | 2 | MP:0010556 | |
| MousePheno | abnormal developmental patterning | 6.79e-04 | 577 | 27 | 6 | MP:0002084 | |
| MousePheno | decreased circulating luteinizing hormone level | 7.38e-04 | 21 | 27 | 2 | MP:0002773 | |
| MousePheno | abnormal fontanelle morphology | 8.86e-04 | 23 | 27 | 2 | MP:0000084 | |
| MousePheno | ventricular hypoplasia | 8.91e-04 | 99 | 27 | 3 | MP:0000279 | |
| MousePheno | abnormal embryonic tissue morphology | 9.04e-04 | 1116 | 27 | 8 | MP:0002085 | |
| MousePheno | abnormal prenatal body size | 9.04e-04 | 1116 | 27 | 8 | MP:0010866 | |
| MousePheno | abnormal heart atrium morphology | 9.61e-04 | 232 | 27 | 4 | MP:0003105 | |
| MousePheno | decreased length of long bones | 9.92e-04 | 409 | 27 | 5 | MP:0004686 | |
| MousePheno | heart hypoplasia | 9.99e-04 | 103 | 27 | 3 | MP:0002740 | |
| MousePheno | prenatal lethality prior to heart atrial septation, incomplete penetrance | 1.00e-03 | 410 | 27 | 5 | MP:0031660 | |
| MousePheno | embryonic lethality, incomplete penetrance | 1.00e-03 | 410 | 27 | 5 | MP:0011102 | |
| MousePheno | abnormal vitelline vasculature morphology | 1.01e-03 | 235 | 27 | 4 | MP:0003229 | |
| MousePheno | abnormal circulating leptin level | 1.02e-03 | 236 | 27 | 4 | MP:0005667 | |
| MousePheno | pallor | 1.07e-03 | 239 | 27 | 4 | MP:0003717 | |
| MousePheno | abnormal interatrial septum morphology | 1.12e-03 | 107 | 27 | 3 | MP:0000282 | |
| MousePheno | increased hormone level | 1.18e-03 | 641 | 27 | 6 | MP:0014454 | |
| MousePheno | abnormal retina development | 1.32e-03 | 28 | 27 | 2 | MP:0009772 | |
| MousePheno | abnormal ventricle myocardium morphology | 1.41e-03 | 116 | 27 | 3 | MP:0010499 | |
| MousePheno | abnormal primitive streak formation | 1.41e-03 | 116 | 27 | 3 | MP:0002230 | |
| MousePheno | ventricular septal defect | 1.49e-03 | 261 | 27 | 4 | MP:0010402 | |
| MousePheno | increased adiponectin level | 1.51e-03 | 30 | 27 | 2 | MP:0004892 | |
| MousePheno | embryonic lethality during organogenesis, incomplete penetrance | 1.64e-03 | 268 | 27 | 4 | MP:0011108 | |
| MousePheno | decreased luteinizing hormone level | 1.72e-03 | 32 | 27 | 2 | MP:0005132 | |
| MousePheno | abnormal visceral yolk sac blood island morphology | 1.72e-03 | 32 | 27 | 2 | MP:0011204 | |
| MousePheno | increased circulating leptin level | 1.75e-03 | 125 | 27 | 3 | MP:0005669 | |
| MousePheno | abnormal circulating hormone level | 1.79e-03 | 954 | 27 | 7 | MP:0005418 | |
| MousePheno | abnormal gastrulation | 1.82e-03 | 469 | 27 | 5 | MP:0001695 | |
| MousePheno | abnormal embryonic-extraembryonic boundary morphology | 1.94e-03 | 34 | 27 | 2 | MP:0003890 | |
| MousePheno | abnormal malleus morphology | 1.94e-03 | 34 | 27 | 2 | MP:0000029 | |
| MousePheno | increased circulating insulin level | 2.00e-03 | 283 | 27 | 4 | MP:0002079 | |
| MousePheno | decreased retina cone cell number | 2.17e-03 | 36 | 27 | 2 | MP:0008446 | |
| MousePheno | abnormal pituitary gland morphology | 2.17e-03 | 135 | 27 | 3 | MP:0000633 | |
| MousePheno | abnormal sleep behavior | 2.27e-03 | 137 | 27 | 3 | MP:0011396 | |
| MousePheno | decreased brain size | 2.32e-03 | 295 | 27 | 4 | MP:0000774 | |
| MousePheno | abnormal diencephalon morphology | 2.41e-03 | 298 | 27 | 4 | MP:0000830 | |
| MousePheno | abnormal circulating insulin level | 2.52e-03 | 505 | 27 | 5 | MP:0001560 | |
| MousePheno | oligodactyly | 2.55e-03 | 39 | 27 | 2 | MP:0000565 | |
| MousePheno | prenatal lethality, incomplete penetrance | 2.57e-03 | 747 | 27 | 6 | MP:0011101 | |
| MousePheno | abnormal limb morphology | 2.74e-03 | 1028 | 27 | 7 | MP:0002109 | |
| MousePheno | abnormal energy expenditure | 2.88e-03 | 313 | 27 | 4 | MP:0005450 | |
| MousePheno | impaired wound healing | 2.95e-03 | 42 | 27 | 2 | MP:0001792 | |
| MousePheno | effusion | 3.04e-03 | 152 | 27 | 3 | MP:0021205 | |
| MousePheno | abnormal palate morphology | 3.15e-03 | 321 | 27 | 4 | MP:0003755 | |
| MousePheno | abnormal energy homeostasis | 3.19e-03 | 322 | 27 | 4 | MP:0005448 | |
| MousePheno | abnormal hypothalamus morphology | 3.23e-03 | 44 | 27 | 2 | MP:0000837 | |
| MousePheno | abnormal effector memory T-helper cell number | 3.23e-03 | 44 | 27 | 2 | MP:0013770 | |
| MousePheno | abnormal adipose tissue morphology | 3.24e-03 | 1361 | 27 | 8 | MP:0000003 | |
| MousePheno | abnormal neuroendocrine gland morphology | 3.28e-03 | 156 | 27 | 3 | MP:0000631 | |
| MousePheno | increased megakaryocyte cell number | 3.38e-03 | 45 | 27 | 2 | MP:0008254 | |
| MousePheno | craniofacial phenotype | 3.41e-03 | 1372 | 27 | 8 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 3.41e-03 | 1372 | 27 | 8 | MP:0000428 | |
| MousePheno | abnormal forebrain morphology | 3.47e-03 | 1072 | 27 | 7 | MP:0000783 | |
| Domain | Bromodomain_CS | 7.89e-08 | 26 | 30 | 4 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 3.44e-07 | 37 | 30 | 4 | PS00633 | |
| Domain | Bromodomain | 3.84e-07 | 38 | 30 | 4 | PF00439 | |
| Domain | BROMODOMAIN_2 | 5.25e-07 | 41 | 30 | 4 | PS50014 | |
| Domain | BROMO | 5.80e-07 | 42 | 30 | 4 | SM00297 | |
| Domain | Bromodomain | 5.80e-07 | 42 | 30 | 4 | IPR001487 | |
| Domain | - | 5.80e-07 | 42 | 30 | 4 | 1.20.920.10 | |
| Domain | - | 2.49e-06 | 2 | 30 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 2.49e-06 | 2 | 30 | 2 | PF02135 | |
| Domain | ZF_TAZ | 2.49e-06 | 2 | 30 | 2 | PS50134 | |
| Domain | Nuc_rcpt_coact_CREBbp | 2.49e-06 | 2 | 30 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 2.49e-06 | 2 | 30 | 2 | PF08214 | |
| Domain | KIX | 2.49e-06 | 2 | 30 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 2.49e-06 | 2 | 30 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 2.49e-06 | 2 | 30 | 2 | IPR031162 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 2.49e-06 | 2 | 30 | 2 | IPR013178 | |
| Domain | DUF902 | 2.49e-06 | 2 | 30 | 2 | PF06001 | |
| Domain | - | 2.49e-06 | 2 | 30 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 2.49e-06 | 2 | 30 | 2 | IPR010303 | |
| Domain | KAT11 | 2.49e-06 | 2 | 30 | 2 | SM01250 | |
| Domain | - | 2.49e-06 | 2 | 30 | 2 | 1.10.1630.10 | |
| Domain | Znf_TAZ | 2.49e-06 | 2 | 30 | 2 | IPR000197 | |
| Domain | KIX_dom | 2.49e-06 | 2 | 30 | 2 | IPR003101 | |
| Domain | Creb_binding | 2.49e-06 | 2 | 30 | 2 | PF09030 | |
| Domain | KIX | 2.49e-06 | 2 | 30 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 2.49e-06 | 2 | 30 | 2 | PS51727 | |
| Domain | Nuc_rcpt_coact | 3.73e-05 | 6 | 30 | 2 | IPR009110 | |
| Domain | ZF_ZZ_2 | 3.76e-04 | 18 | 30 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 3.76e-04 | 18 | 30 | 2 | PS01357 | |
| Domain | ZZ | 3.76e-04 | 18 | 30 | 2 | PF00569 | |
| Domain | PHD | 3.87e-04 | 89 | 30 | 3 | SM00249 | |
| Domain | Znf_PHD | 4.13e-04 | 91 | 30 | 3 | IPR001965 | |
| Domain | Znf_ZZ | 4.19e-04 | 19 | 30 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 4.19e-04 | 19 | 30 | 2 | SM00291 | |
| Domain | ZF_PHD_2 | 4.69e-04 | 95 | 30 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 4.83e-04 | 96 | 30 | 3 | PS01359 | |
| Domain | EPHD | 5.65e-04 | 22 | 30 | 2 | PS51805 | |
| Domain | Znf_FYVE_PHD | 1.66e-03 | 147 | 30 | 3 | IPR011011 | |
| Domain | Homeodomain-like | 1.87e-03 | 332 | 30 | 4 | IPR009057 | |
| Domain | Homeobox_CS | 3.24e-03 | 186 | 30 | 3 | IPR017970 | |
| Domain | CH | 4.87e-03 | 65 | 30 | 2 | SM00033 | |
| Domain | CH | 5.63e-03 | 70 | 30 | 2 | PF00307 | |
| Domain | - | 5.79e-03 | 71 | 30 | 2 | 1.10.418.10 | |
| Domain | CH | 6.11e-03 | 73 | 30 | 2 | PS50021 | |
| Domain | Homeobox | 6.14e-03 | 234 | 30 | 3 | PF00046 | |
| Domain | HOMEOBOX_1 | 6.29e-03 | 236 | 30 | 3 | PS00027 | |
| Domain | HOX | 6.36e-03 | 237 | 30 | 3 | SM00389 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.29e-07 | 237 | 25 | 7 | M27786 | |
| Pathway | REACTOME_HEME_SIGNALING | 1.54e-06 | 49 | 25 | 4 | M41832 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | MED25 SMARCA2 PAK3 KMT2C NCOA6 TSC22D1 ISL1 OTX2 CREBBP YAP1 EP300 TNRC6A | 1.70e-06 | 1432 | 25 | 12 | M509 |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.75e-06 | 118 | 25 | 5 | M27316 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 3.30e-06 | 17 | 25 | 3 | M48025 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 3.95e-06 | 18 | 25 | 3 | M26942 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 4.84e-06 | 65 | 25 | 4 | M39682 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 6.35e-06 | 272 | 25 | 6 | M29619 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 6.42e-06 | 21 | 25 | 3 | M27485 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 6.52e-06 | 70 | 25 | 4 | M938 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 1.35e-05 | 84 | 25 | 4 | M1008 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 1.40e-05 | 27 | 25 | 3 | M26943 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 1.75e-05 | 29 | 25 | 3 | M48076 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 3.01e-05 | 5 | 25 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 3.01e-05 | 5 | 25 | 2 | M48020 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 3.01e-05 | 5 | 25 | 2 | M27228 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 3.01e-05 | 5 | 25 | 2 | M48023 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 3.68e-05 | 37 | 25 | 3 | M27797 | |
| Pathway | REACTOME_ADIPOGENESIS | 3.91e-05 | 110 | 25 | 4 | M48259 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 4.51e-05 | 6 | 25 | 2 | M22062 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 5.87e-05 | 122 | 25 | 4 | M29689 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 6.31e-05 | 7 | 25 | 2 | MM1573 | |
| Pathway | REACTOME_GASTRULATION | 7.29e-05 | 129 | 25 | 4 | M46433 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 8.40e-05 | 8 | 25 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 8.40e-05 | 8 | 25 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 8.40e-05 | 8 | 25 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 8.40e-05 | 8 | 25 | 2 | M46443 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 1.08e-04 | 9 | 25 | 2 | M47451 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 1.09e-04 | 143 | 25 | 4 | M39591 | |
| Pathway | PID_AR_TF_PATHWAY | 1.09e-04 | 53 | 25 | 3 | M151 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 1.35e-04 | 10 | 25 | 2 | M27945 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 1.41e-04 | 153 | 25 | 4 | M39546 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 1.64e-04 | 11 | 25 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 1.64e-04 | 11 | 25 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 1.64e-04 | 11 | 25 | 2 | M26924 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 1.97e-04 | 12 | 25 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.97e-04 | 12 | 25 | 2 | M27765 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 2.49e-04 | 70 | 25 | 3 | M13266 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 2.71e-04 | 14 | 25 | 2 | M27808 | |
| Pathway | PID_E2F_PATHWAY | 2.82e-04 | 73 | 25 | 3 | M40 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 3.13e-04 | 15 | 25 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 3.13e-04 | 15 | 25 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 3.13e-04 | 15 | 25 | 2 | MM1439 | |
| Pathway | WP_RUBINSTEINTAYBI_SYNDROME_1 | 3.13e-04 | 15 | 25 | 2 | M48323 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 3.13e-04 | 15 | 25 | 2 | M953 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 3.57e-04 | 16 | 25 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 3.57e-04 | 16 | 25 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 3.57e-04 | 16 | 25 | 2 | M8516 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 3.57e-04 | 16 | 25 | 2 | M27121 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 3.57e-04 | 16 | 25 | 2 | M27940 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 4.04e-04 | 17 | 25 | 2 | MM1509 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 4.04e-04 | 17 | 25 | 2 | MM15215 | |
| Pathway | PID_CMYB_PATHWAY | 4.27e-04 | 84 | 25 | 3 | M195 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 5.07e-04 | 19 | 25 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 5.07e-04 | 19 | 25 | 2 | M46442 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 5.63e-04 | 20 | 25 | 2 | M27881 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 6.21e-04 | 21 | 25 | 2 | M39593 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 6.31e-04 | 96 | 25 | 3 | M27792 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 6.31e-04 | 96 | 25 | 3 | M27784 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 6.71e-04 | 98 | 25 | 3 | M48247 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 6.82e-04 | 22 | 25 | 2 | MM1443 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 6.82e-04 | 22 | 25 | 2 | MM1370 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 7.47e-04 | 23 | 25 | 2 | M2821 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 8.14e-04 | 24 | 25 | 2 | M13404 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 8.83e-04 | 25 | 25 | 2 | M27880 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 9.56e-04 | 26 | 25 | 2 | M2499 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 9.56e-04 | 26 | 25 | 2 | M32 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 9.66e-04 | 254 | 25 | 4 | M27131 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 1.11e-03 | 28 | 25 | 2 | M48253 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 1.11e-03 | 28 | 25 | 2 | M27254 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 1.18e-03 | 119 | 25 | 3 | M607 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 1.21e-03 | 120 | 25 | 3 | M48233 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.27e-03 | 30 | 25 | 2 | M207 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 1.27e-03 | 30 | 25 | 2 | M936 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 1.45e-03 | 32 | 25 | 2 | M39521 | |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | 1.45e-03 | 128 | 25 | 3 | M48019 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 1.64e-03 | 34 | 25 | 2 | M39771 | |
| Pathway | PID_HIF2PATHWAY | 1.64e-03 | 34 | 25 | 2 | M44 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 1.64e-03 | 34 | 25 | 2 | M46422 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 1.73e-03 | 35 | 25 | 2 | M48246 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.77e-03 | 137 | 25 | 3 | M48232 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.81e-03 | 301 | 25 | 4 | MM15983 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 1.88e-03 | 140 | 25 | 3 | M27484 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 1.94e-03 | 37 | 25 | 2 | M29790 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 1.96e-03 | 142 | 25 | 3 | M27233 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | 2.02e-03 | 1387 | 25 | 8 | M734 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 2.04e-03 | 38 | 25 | 2 | M27757 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 2.04e-03 | 38 | 25 | 2 | M27255 | |
| Pathway | WP_MALE_INFERTILITY | 2.08e-03 | 145 | 25 | 3 | M39856 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 2.24e-03 | 149 | 25 | 3 | M27888 | |
| Pathway | PID_FOXM1_PATHWAY | 2.26e-03 | 40 | 25 | 2 | M176 | |
| Pathway | PID_IFNG_PATHWAY | 2.26e-03 | 40 | 25 | 2 | M161 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 2.49e-03 | 42 | 25 | 2 | M17541 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 2.49e-03 | 42 | 25 | 2 | M48018 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 2.49e-03 | 42 | 25 | 2 | M27172 | |
| Pathway | PID_HNF3A_PATHWAY | 2.73e-03 | 44 | 25 | 2 | M285 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 2.73e-03 | 44 | 25 | 2 | M27295 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 3.11e-03 | 47 | 25 | 2 | M7946 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 3.11e-03 | 47 | 25 | 2 | M29777 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 3.11e-03 | 47 | 25 | 2 | M39829 | |
| Pubmed | PAK3 MACF1 KMT2C TSC22D1 BICRAL SIK3 TCF20 CPLANE1 CREBBP EP300 ARID2 TNRC6A | 3.34e-15 | 486 | 30 | 12 | 20936779 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TRERF1 SMARCA2 BPTF KMT2C NCOA6 OTX2 TCF20 CREBBP EP300 ARID2 | 2.42e-13 | 351 | 30 | 10 | 38297188 |
| Pubmed | 2.00e-11 | 549 | 30 | 10 | 38280479 | ||
| Pubmed | TRERF1 SMARCA2 BPTF KMT2C NCOA6 TCF20 SMG7 ANKHD1 CREBBP YAP1 EP300 ARID2 TNRC6A | 5.62e-11 | 1429 | 30 | 13 | 35140242 | |
| Pubmed | CUL4B SMARCA2 BPTF MACF1 BICRAL SIK3 SMG7 ANKHD1 CREBBP EP300 ARID2 TNRC6A | 5.70e-11 | 1116 | 30 | 12 | 31753913 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 1.21e-10 | 457 | 30 | 9 | 32344865 | |
| Pubmed | 4.39e-10 | 529 | 30 | 9 | 14621295 | ||
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 11349124 | ||
| Pubmed | CBP/p300 is a cell type-specific modulator of CLOCK/BMAL1-mediated transcription. | 2.32e-09 | 4 | 30 | 3 | 19922678 | |
| Pubmed | 2.32e-09 | 4 | 30 | 3 | 28398509 | ||
| Pubmed | 4.17e-09 | 157 | 30 | 6 | 30186101 | ||
| Pubmed | 5.78e-09 | 5 | 30 | 3 | 11912212 | ||
| Pubmed | 9.31e-09 | 83 | 30 | 5 | 28794006 | ||
| Pubmed | Coactivation of the CLOCK-BMAL1 complex by CBP mediates resetting of the circadian clock. | 1.16e-08 | 6 | 30 | 3 | 20930143 | |
| Pubmed | TRERF1 SMARCA2 BPTF KMT2C NCOA6 BICRAL TCF20 CREBBP EP300 ARID2 | 1.67e-08 | 1103 | 30 | 10 | 34189442 | |
| Pubmed | 2.02e-08 | 7 | 30 | 3 | 16332960 | ||
| Pubmed | A switch from hBrm to Brg1 at IFNγ-activated sequences mediates the activation of human genes. | 2.02e-08 | 7 | 30 | 3 | 21079652 | |
| Pubmed | 2.02e-08 | 7 | 30 | 3 | 27462461 | ||
| Pubmed | 3.58e-08 | 225 | 30 | 6 | 12168954 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 3.96e-08 | 398 | 30 | 7 | 35016035 | |
| Pubmed | 1.01e-07 | 268 | 30 | 6 | 33640491 | ||
| Pubmed | 1.13e-07 | 709 | 30 | 8 | 22988430 | ||
| Pubmed | 1.27e-07 | 12 | 30 | 3 | 12189208 | ||
| Pubmed | Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. | 1.27e-07 | 12 | 30 | 3 | 14645221 | |
| Pubmed | 1.65e-07 | 13 | 30 | 3 | 19524524 | ||
| Pubmed | 1.72e-07 | 57 | 30 | 4 | 18022353 | ||
| Pubmed | Role of Shh in the development of molecularly characterized tegmental nuclei in mouse rhombomere 1. | 2.09e-07 | 14 | 30 | 3 | 23494735 | |
| Pubmed | MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation. | 2.09e-07 | 14 | 30 | 3 | 17641689 | |
| Pubmed | 2.09e-07 | 14 | 30 | 3 | 12482968 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.20e-07 | 774 | 30 | 8 | 15302935 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | AAK1 SMARCA2 PAK3 BPTF MACF1 KMT2C TSC22D1 SMG7 CREBBP EP300 | 2.75e-07 | 1489 | 30 | 10 | 28611215 |
| Pubmed | 3.05e-07 | 808 | 30 | 8 | 20412781 | ||
| Pubmed | 3.12e-07 | 66 | 30 | 4 | 23275444 | ||
| Pubmed | 3.22e-07 | 16 | 30 | 3 | 23870121 | ||
| Pubmed | A human RNA polymerase II complex containing factors that modify chromatin structure. | 3.22e-07 | 16 | 30 | 3 | 9710619 | |
| Pubmed | 3.91e-07 | 17 | 30 | 3 | 26180087 | ||
| Pubmed | 3.91e-07 | 17 | 30 | 3 | 18330926 | ||
| Pubmed | 3.91e-07 | 17 | 30 | 3 | 19183483 | ||
| Pubmed | 3.91e-07 | 17 | 30 | 3 | 28291835 | ||
| Pubmed | 5.24e-07 | 75 | 30 | 4 | 25593309 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 5.53e-07 | 588 | 30 | 7 | 38580884 | |
| Pubmed | 5.56e-07 | 19 | 30 | 3 | 18329113 | ||
| Pubmed | 6.54e-07 | 20 | 30 | 3 | 11877444 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 7.19e-07 | 2 | 30 | 2 | 34845315 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19729597 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 15860545 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 29460469 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 7.19e-07 | 2 | 30 | 2 | 24551300 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 33911074 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 9018065 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24648406 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 30135524 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 39287984 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 7.19e-07 | 2 | 30 | 2 | 16596650 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24726915 | ||
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 7.19e-07 | 2 | 30 | 2 | 29217654 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20717166 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 10049825 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 7.19e-07 | 2 | 30 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 7.19e-07 | 2 | 30 | 2 | 29170789 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 25893291 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 11559821 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 21555743 | ||
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 7.19e-07 | 2 | 30 | 2 | 12646247 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 32576962 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19822209 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24522976 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 11867645 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 7.19e-07 | 2 | 30 | 2 | 21847097 | |
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 7.19e-07 | 2 | 30 | 2 | 11963968 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 7.19e-07 | 2 | 30 | 2 | 34813504 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 7.19e-07 | 2 | 30 | 2 | 12696060 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20301699 | ||
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 7.19e-07 | 2 | 30 | 2 | 36109165 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24639469 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 37816914 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 12242694 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 7.19e-07 | 2 | 30 | 2 | 11438528 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 10918613 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 31182547 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 35502657 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 30635043 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 31898871 | ||
| Pubmed | Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. | 7.19e-07 | 2 | 30 | 2 | 27648933 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 32319569 | ||
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 7.19e-07 | 2 | 30 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 7.19e-07 | 2 | 30 | 2 | 27881443 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19272189 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 10610021 | ||
| Pubmed | Emerging roles of p300/CBP in autophagy and autophagy-related human disorders. | 7.19e-07 | 2 | 30 | 2 | 37314181 | |
| Pubmed | Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. | 7.19e-07 | 2 | 30 | 2 | 12397173 | |
| Pubmed | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. | 7.19e-07 | 2 | 30 | 2 | 15641773 | |
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 7.19e-07 | 2 | 30 | 2 | 32690000 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 9733868 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 30953353 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 21803292 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 9811832 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24089570 | ||
| Interaction | SOX9 interactions | 8.93e-11 | 97 | 30 | 7 | int:SOX9 | |
| Interaction | HNF1B interactions | 2.64e-10 | 190 | 30 | 8 | int:HNF1B | |
| Interaction | SOX2 interactions | TRERF1 CUL4B SMARCA2 BPTF MACF1 KMT2C NCOA6 TCF20 ANKHD1 CPLANE1 CLOCK YAP1 EP300 ARID2 TNRC6A | 2.81e-10 | 1422 | 30 | 15 | int:SOX2 |
| Interaction | WWTR1 interactions | 3.01e-10 | 422 | 30 | 10 | int:WWTR1 | |
| Interaction | TBXT interactions | 3.18e-10 | 116 | 30 | 7 | int:TBXT | |
| Interaction | NCOA6 interactions | 1.53e-09 | 145 | 30 | 7 | int:NCOA6 | |
| Interaction | SOX7 interactions | 2.07e-09 | 82 | 30 | 6 | int:SOX7 | |
| Interaction | TLE3 interactions | 2.52e-09 | 376 | 30 | 9 | int:TLE3 | |
| Interaction | CRX interactions | 2.63e-09 | 254 | 30 | 8 | int:CRX | |
| Interaction | SMAD2 interactions | 3.10e-09 | 385 | 30 | 9 | int:SMAD2 | |
| Interaction | EGR2 interactions | 4.84e-09 | 171 | 30 | 7 | int:EGR2 | |
| Interaction | HNF4A interactions | 4.90e-09 | 275 | 30 | 8 | int:HNF4A | |
| Interaction | ARID1A interactions | 5.04e-09 | 276 | 30 | 8 | int:ARID1A | |
| Interaction | TEAD1 interactions | 5.91e-09 | 176 | 30 | 7 | int:TEAD1 | |
| Interaction | NUP35 interactions | 7.18e-09 | 424 | 30 | 9 | int:NUP35 | |
| Interaction | SP7 interactions | 1.07e-08 | 304 | 30 | 8 | int:SP7 | |
| Interaction | KLF5 interactions | 1.20e-08 | 195 | 30 | 7 | int:KLF5 | |
| Interaction | SMARCA4 interactions | 1.51e-08 | 462 | 30 | 9 | int:SMARCA4 | |
| Interaction | FEV interactions | 1.59e-08 | 203 | 30 | 7 | int:FEV | |
| Interaction | SMARCB1 interactions | 4.34e-08 | 364 | 30 | 8 | int:SMARCB1 | |
| Interaction | CREBBP interactions | 1.40e-07 | 599 | 30 | 9 | int:CREBBP | |
| Interaction | IRF4 interactions | 1.55e-07 | 85 | 30 | 5 | int:IRF4 | |
| Interaction | TRERF1 interactions | 1.58e-07 | 33 | 30 | 4 | int:TRERF1 | |
| Interaction | KMT2D interactions | 1.60e-07 | 169 | 30 | 6 | int:KMT2D | |
| Interaction | RBBP5 interactions | 1.70e-07 | 287 | 30 | 7 | int:RBBP5 | |
| Interaction | TLX3 interactions | 1.87e-07 | 291 | 30 | 7 | int:TLX3 | |
| Interaction | FOXI1 interactions | 2.31e-07 | 92 | 30 | 5 | int:FOXI1 | |
| Interaction | PPARG interactions | 2.68e-07 | 307 | 30 | 7 | int:PPARG | |
| Interaction | SOX17 interactions | 2.72e-07 | 95 | 30 | 5 | int:SOX17 | |
| Interaction | LHX3 interactions | 2.73e-07 | 185 | 30 | 6 | int:LHX3 | |
| Interaction | FOS interactions | 2.99e-07 | 312 | 30 | 7 | int:FOS | |
| Interaction | JUN interactions | 3.07e-07 | 470 | 30 | 8 | int:JUN | |
| Interaction | SS18L1 interactions | 3.17e-07 | 98 | 30 | 5 | int:SS18L1 | |
| Interaction | LHX1 interactions | 4.07e-07 | 103 | 30 | 5 | int:LHX1 | |
| Interaction | GATA2 interactions | 4.19e-07 | 199 | 30 | 6 | int:GATA2 | |
| Interaction | ZYX interactions | 4.27e-07 | 329 | 30 | 7 | int:ZYX | |
| Interaction | H2AC4 interactions | 5.38e-07 | 506 | 30 | 8 | int:H2AC4 | |
| Interaction | RBBP7 interactions | 5.46e-07 | 507 | 30 | 8 | int:RBBP7 | |
| Interaction | RORC interactions | 5.70e-07 | 45 | 30 | 4 | int:RORC | |
| Interaction | KDM1A interactions | TRERF1 SMARCA2 ISL1 TCF20 SMG7 ANKHD1 CLOCK YAP1 EP300 TNRC6A | 6.01e-07 | 941 | 30 | 10 | int:KDM1A |
| Interaction | RORB interactions | 6.81e-07 | 47 | 30 | 4 | int:RORB | |
| Interaction | ERG interactions | 8.16e-07 | 223 | 30 | 6 | int:ERG | |
| Interaction | NCOR1 interactions | 8.27e-07 | 363 | 30 | 7 | int:NCOR1 | |
| Interaction | ASCL2 interactions | 8.43e-07 | 13 | 30 | 3 | int:ASCL2 | |
| Interaction | PAX6 interactions | 8.74e-07 | 366 | 30 | 7 | int:PAX6 | |
| Interaction | CEBPA interactions | TRERF1 SMARCA2 BPTF MACF1 KMT2C NCOA6 BICRAL TCF20 CREBBP EP300 ARID2 | 8.78e-07 | 1245 | 30 | 11 | int:CEBPA |
| Interaction | ETS1 interactions | 9.07e-07 | 121 | 30 | 5 | int:ETS1 | |
| Interaction | AR interactions | TRERF1 CUL4B SMARCA2 KMT2C NCOA6 TCF20 CREBBP YAP1 EP300 ARID2 | 9.73e-07 | 992 | 30 | 10 | int:AR |
| Interaction | SIN3A interactions | 1.12e-06 | 380 | 30 | 7 | int:SIN3A | |
| Interaction | PAX9 interactions | 1.29e-06 | 130 | 30 | 5 | int:PAX9 | |
| Interaction | KMT2B interactions | 1.29e-06 | 130 | 30 | 5 | int:KMT2B | |
| Interaction | SMAD1 interactions | 1.35e-06 | 243 | 30 | 6 | int:SMAD1 | |
| Interaction | RBBP4 interactions | 1.37e-06 | 573 | 30 | 8 | int:RBBP4 | |
| Interaction | KMT2C interactions | 1.50e-06 | 134 | 30 | 5 | int:KMT2C | |
| Interaction | MED23 interactions | 2.27e-06 | 266 | 30 | 6 | int:MED23 | |
| Interaction | ELF5 interactions | 2.37e-06 | 147 | 30 | 5 | int:ELF5 | |
| Interaction | YAP1 interactions | TRERF1 SMARCA2 BPTF KMT2C NCOA6 TCF20 CREBBP YAP1 EP300 ARID2 | 2.38e-06 | 1095 | 30 | 10 | int:YAP1 |
| Interaction | WDR5 interactions | CUL4B SMARCA2 MACF1 KMT2C NCOA6 ANKHD1 CREBBP YAP1 EP300 TNRC6A | 2.50e-06 | 1101 | 30 | 10 | int:WDR5 |
| Interaction | BAG2 interactions | 2.53e-06 | 622 | 30 | 8 | int:BAG2 | |
| Interaction | HDAC1 interactions | TRERF1 CUL4B SMARCA2 BPTF TCF20 ANKHD1 CREBBP YAP1 EP300 TNRC6A | 2.65e-06 | 1108 | 30 | 10 | int:HDAC1 |
| Interaction | GCM1 interactions | 3.04e-06 | 68 | 30 | 4 | int:GCM1 | |
| Interaction | SMAD3 interactions | 3.30e-06 | 447 | 30 | 7 | int:SMAD3 | |
| Interaction | RXRA interactions | 4.70e-06 | 169 | 30 | 5 | int:RXRA | |
| Interaction | SETD1A interactions | 4.84e-06 | 170 | 30 | 5 | int:SETD1A | |
| Interaction | NANOG interactions | 5.34e-06 | 481 | 30 | 7 | int:NANOG | |
| Interaction | TLX1 interactions | 5.57e-06 | 175 | 30 | 5 | int:TLX1 | |
| Interaction | ARID1B interactions | 5.89e-06 | 177 | 30 | 5 | int:ARID1B | |
| Interaction | KMT2A interactions | 5.91e-06 | 314 | 30 | 6 | int:KMT2A | |
| Interaction | IRF1 interactions | 6.76e-06 | 83 | 30 | 4 | int:IRF1 | |
| Interaction | HOXB7 interactions | 7.56e-06 | 26 | 30 | 3 | int:HOXB7 | |
| Interaction | CDX2 interactions | 7.78e-06 | 86 | 30 | 4 | int:CDX2 | |
| Interaction | MYOD1 interactions | 9.20e-06 | 194 | 30 | 5 | int:MYOD1 | |
| Interaction | SMARCA2 interactions | 1.03e-05 | 346 | 30 | 6 | int:SMARCA2 | |
| Interaction | SMARCC2 interactions | 1.15e-05 | 353 | 30 | 6 | int:SMARCC2 | |
| Interaction | PRPH interactions | 1.17e-05 | 204 | 30 | 5 | int:PRPH | |
| Interaction | HOXD4 interactions | 1.18e-05 | 30 | 30 | 3 | int:HOXD4 | |
| Interaction | MED1 interactions | 1.23e-05 | 206 | 30 | 5 | int:MED1 | |
| Interaction | RARA interactions | 1.80e-05 | 223 | 30 | 5 | int:RARA | |
| Interaction | SMARCC1 interactions | 1.86e-05 | 384 | 30 | 6 | int:SMARCC1 | |
| Interaction | NFIX interactions | 1.96e-05 | 227 | 30 | 5 | int:NFIX | |
| Interaction | KLF3 interactions | 2.01e-05 | 228 | 30 | 5 | int:KLF3 | |
| Interaction | PAX8 interactions | 2.14e-05 | 111 | 30 | 4 | int:PAX8 | |
| Interaction | THRA interactions | 2.14e-05 | 111 | 30 | 4 | int:THRA | |
| Interaction | RB1 interactions | 2.14e-05 | 394 | 30 | 6 | int:RB1 | |
| Interaction | ANAPC2 interactions | 2.27e-05 | 234 | 30 | 5 | int:ANAPC2 | |
| Interaction | H2BC3 interactions | 2.54e-05 | 406 | 30 | 6 | int:H2BC3 | |
| Interaction | DDIT3 interactions | 2.91e-05 | 120 | 30 | 4 | int:DDIT3 | |
| Interaction | TFF1 interactions | 3.05e-05 | 41 | 30 | 3 | int:TFF1 | |
| Interaction | NPAS2 interactions | 3.29e-05 | 42 | 30 | 3 | int:NPAS2 | |
| Interaction | PAX7 interactions | 3.31e-05 | 124 | 30 | 4 | int:PAX7 | |
| Interaction | PPIA interactions | 3.39e-05 | 888 | 30 | 8 | int:PPIA | |
| Interaction | ARNT interactions | 3.43e-05 | 255 | 30 | 5 | int:ARNT | |
| Interaction | RUNX2 interactions | 3.52e-05 | 126 | 30 | 4 | int:RUNX2 | |
| Interaction | SMAD7 interactions | 3.63e-05 | 127 | 30 | 4 | int:SMAD7 | |
| Interaction | MTA2 interactions | 3.74e-05 | 435 | 30 | 6 | int:MTA2 | |
| Interaction | TET1 interactions | 4.05e-05 | 45 | 30 | 3 | int:TET1 | |
| Interaction | ASH2L interactions | 4.12e-05 | 265 | 30 | 5 | int:ASH2L | |
| Interaction | CXXC1 interactions | 4.22e-05 | 132 | 30 | 4 | int:CXXC1 | |
| Interaction | NR1I2 interactions | 4.92e-05 | 48 | 30 | 3 | int:NR1I2 | |
| Interaction | FXR1 interactions | 4.94e-05 | 679 | 30 | 7 | int:FXR1 | |
| Cytoband | Xq23 | 5.36e-04 | 52 | 30 | 2 | Xq23 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 6.63e-07 | 17 | 19 | 3 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.58e-04 | 18 | 19 | 2 | 91 | |
| GeneFamily | PHD finger proteins | 3.97e-03 | 90 | 19 | 2 | 88 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 4.14e-03 | 92 | 19 | 2 | 521 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 3.97e-08 | 467 | 30 | 8 | M1347 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 5.23e-08 | 484 | 30 | 8 | MM999 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.79e-06 | 180 | 30 | 5 | M8239 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP | 2.93e-06 | 199 | 30 | 5 | M7596 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | AAK1 TRERF1 SMARCA2 BPTF MACF1 KMT2C SIK3 CREBBP EP300 ARID2 | 3.64e-06 | 1492 | 30 | 10 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 3.87e-06 | 856 | 30 | 8 | M4500 | |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 4.20e-05 | 171 | 30 | 4 | M39234 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 7.14e-05 | 196 | 30 | 4 | M5381 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP | 7.57e-05 | 199 | 30 | 4 | M9964 | |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 7.57e-05 | 199 | 30 | 4 | M7607 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 1.17e-04 | 429 | 30 | 5 | M29 | |
| Coexpression | BENPORATH_SOX2_TARGETS | 1.58e-04 | 734 | 30 | 6 | M3835 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.72e-04 | 466 | 30 | 5 | M13522 | |
| Coexpression | BILD_HRAS_ONCOGENIC_SIGNATURE | 1.88e-04 | 252 | 30 | 4 | M12029 | |
| Coexpression | HAHTOLA_MYCOSIS_FUNGOIDES_UP | 1.92e-04 | 18 | 30 | 2 | M6714 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_VS_70PLS_0DY_UP | 2.88e-04 | 22 | 30 | 2 | M40867 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM | 2.88e-04 | 22 | 30 | 2 | M14523 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM | 2.88e-04 | 22 | 30 | 2 | MM676 | |
| Coexpression | PASINI_SUZ12_TARGETS_UP | 2.91e-04 | 113 | 30 | 3 | M2291 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | 2.91e-04 | 822 | 30 | 6 | M6782 | |
| Coexpression | BENPORATH_OCT4_TARGETS | 3.21e-04 | 290 | 30 | 4 | M17183 | |
| Coexpression | PASINI_SUZ12_TARGETS_UP | 3.91e-04 | 125 | 30 | 3 | MM1065 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | 5.04e-04 | 911 | 30 | 6 | M40038 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.52e-05 | 595 | 30 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.43e-06 | 188 | 30 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 8.08e-06 | 192 | 30 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 8.24e-06 | 193 | 30 | 4 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.94e-06 | 197 | 30 | 4 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.55e-04 | 156 | 30 | 3 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.64e-04 | 159 | 30 | 3 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.73e-04 | 162 | 30 | 3 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.93e-04 | 168 | 30 | 3 | 27cdf5cfa1d906868cfd60fdfab3cd51f3b3602f | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 2.14e-04 | 174 | 30 | 3 | 390bd41ef114464f3db3e0cac4e67fe7571b4c23 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 176 | 30 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.25e-04 | 177 | 30 | 3 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.25e-04 | 177 | 30 | 3 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.25e-04 | 177 | 30 | 3 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.25e-04 | 177 | 30 | 3 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 2.25e-04 | 177 | 30 | 3 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 180 | 30 | 3 | 8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.40e-04 | 181 | 30 | 3 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 2.48e-04 | 183 | 30 | 3 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic-progenitor_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.56e-04 | 185 | 30 | 3 | 2c07991e0907ded67e21ab2e66be21695842ed01 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.56e-04 | 185 | 30 | 3 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.60e-04 | 186 | 30 | 3 | 855c2e5a8a6cf94c7de31982e0e2416f924439d3 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.60e-04 | 186 | 30 | 3 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.60e-04 | 186 | 30 | 3 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.60e-04 | 186 | 30 | 3 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.68e-04 | 188 | 30 | 3 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.72e-04 | 189 | 30 | 3 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.77e-04 | 190 | 30 | 3 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 2.77e-04 | 190 | 30 | 3 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 191 | 30 | 3 | fd01a206763dfb6d52cca67123571936b4a8e1a0 | |
| ToppCell | droplet-Pancreas-Endocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-04 | 192 | 30 | 3 | 4510aa262da8dcf7c944b3907a51aba5a9397a4e | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.85e-04 | 192 | 30 | 3 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-04 | 192 | 30 | 3 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-04 | 192 | 30 | 3 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.90e-04 | 193 | 30 | 3 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.90e-04 | 193 | 30 | 3 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 3.03e-04 | 196 | 30 | 3 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | IPF-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 3.03e-04 | 196 | 30 | 3 | 6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.12e-04 | 198 | 30 | 3 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.17e-04 | 199 | 30 | 3 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.17e-04 | 199 | 30 | 3 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.22e-04 | 200 | 30 | 3 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.22e-04 | 200 | 30 | 3 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.22e-04 | 200 | 30 | 3 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.22e-04 | 200 | 30 | 3 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.22e-04 | 200 | 30 | 3 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.22e-04 | 200 | 30 | 3 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Intermediate|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.22e-04 | 200 | 30 | 3 | a3fcd901cb281920f1bafdfd676399a6dc37355e | |
| Drug | AC1L2E0P | 2.59e-06 | 307 | 30 | 6 | CID000019390 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.68e-06 | 170 | 30 | 5 | 1050_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.92e-06 | 173 | 30 | 5 | 2881_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 3.09e-06 | 175 | 30 | 5 | 1058_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.09e-06 | 175 | 30 | 5 | 1014_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.27e-06 | 177 | 30 | 5 | 6434_DN | |
| Drug | Citalopram hydrobromide [59729-32-7]; Down 200; 1uM; PC3; HT_HG-U133A | 5.79e-06 | 199 | 30 | 5 | 4555_DN | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 1.67e-05 | 5 | 30 | 2 | ctd:C575894 | |
| Drug | 5-(4-methylpiperazin-1-yl)-2-(2'-(3,4-dimethoxyphenyl)-5'-benzimidazolyl)benzimidazole | 1.83e-05 | 39 | 30 | 3 | ctd:C477187 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 7.39e-05 | 172 | 30 | 4 | 1072_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 7.73e-05 | 174 | 30 | 4 | 1659_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.73e-05 | 174 | 30 | 4 | 5693_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.08e-05 | 176 | 30 | 4 | 3312_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 8.26e-05 | 177 | 30 | 4 | 1645_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 8.44e-05 | 178 | 30 | 4 | 1112_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 8.44e-05 | 178 | 30 | 4 | 992_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.63e-05 | 179 | 30 | 4 | 5822_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.82e-05 | 180 | 30 | 4 | 3688_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.82e-05 | 180 | 30 | 4 | 1793_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.82e-05 | 180 | 30 | 4 | 4821_DN | |
| Drug | FP-1 | 1.06e-04 | 70 | 30 | 3 | CID000469561 | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 1.13e-04 | 192 | 30 | 4 | 1599_DN | |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.15e-04 | 193 | 30 | 4 | 2076_DN | |
| Drug | Nadide [53-84-9]; Up 200; 6uM; PC3; HT_HG-U133A | 1.18e-04 | 194 | 30 | 4 | 5873_UP | |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 1.18e-04 | 194 | 30 | 4 | 4662_DN | |
| Drug | Gliclazide [21187-98-4]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.20e-04 | 195 | 30 | 4 | 5089_DN | |
| Drug | Flufenamic acid [530-78-9]; Down 200; 14.2uM; HL60; HG-U133A | 1.20e-04 | 195 | 30 | 4 | 1420_DN | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.22e-04 | 196 | 30 | 4 | 7425_UP | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; PC3; HT_HG-U133A | 1.22e-04 | 196 | 30 | 4 | 2065_DN | |
| Drug | Midecamycin [35457-80-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.27e-04 | 198 | 30 | 4 | 5345_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.27e-04 | 198 | 30 | 4 | 7012_UP | |
| Drug | (cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; PC3; HT_HG-U133A | 1.30e-04 | 199 | 30 | 4 | 4543_DN | |
| Drug | EMBLEM | 2.25e-04 | 17 | 30 | 2 | CID000002319 | |
| Drug | 4,4'-DBP | 2.83e-04 | 19 | 30 | 2 | CID000007034 | |
| Disease | Bladder Neoplasm | 2.90e-07 | 140 | 30 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 3.00e-07 | 141 | 30 | 5 | C0005684 | |
| Disease | Menke-Hennekam syndrome | 9.99e-07 | 2 | 30 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 9.99e-07 | 2 | 30 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 9.99e-07 | 2 | 30 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 9.99e-07 | 2 | 30 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 9.99e-07 | 2 | 30 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 9.99e-07 | 2 | 30 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 9.99e-07 | 2 | 30 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 9.99e-07 | 2 | 30 | 2 | C0035934 | |
| Disease | Adenoid Cystic Carcinoma | 3.18e-06 | 100 | 30 | 4 | C0010606 | |
| Disease | Carcinoma, Transitional Cell | 9.85e-06 | 41 | 30 | 3 | C0007138 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.43e-05 | 195 | 30 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 7.74e-05 | 13 | 30 | 2 | C0265338 | |
| Disease | Squamous cell carcinoma of esophagus | 1.23e-04 | 95 | 30 | 3 | C0279626 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.57e-04 | 103 | 30 | 3 | EFO_0008595, EFO_0020944 | |
| Disease | Sezary Syndrome | 3.45e-04 | 27 | 30 | 2 | C0036920 | |
| Disease | calcium measurement | 3.94e-04 | 628 | 30 | 5 | EFO_0004838 | |
| Disease | prostate cancer (is_marker_for) | 5.30e-04 | 156 | 30 | 3 | DOID:10283 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | 6.43e-04 | 1074 | 30 | 6 | C0006142 | |
| Disease | Leukemia, Myelocytic, Acute | 7.16e-04 | 173 | 30 | 3 | C0023467 | |
| Disease | smoking status measurement | 9.62e-04 | 1160 | 30 | 6 | EFO_0006527 | |
| Disease | Endogenous depression | 1.01e-03 | 46 | 30 | 2 | C0011573 | |
| Disease | Intellectual Disability | 1.04e-03 | 447 | 30 | 4 | C3714756 | |
| Disease | Neuroblastoma | 1.05e-03 | 47 | 30 | 2 | C0027819 | |
| Disease | metabolic syndrome | 1.09e-03 | 200 | 30 | 3 | EFO_0000195 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQMMQQQQQQGAGPG | 2186 | Q09472 | |
| PVVSQGGSQQQLMQN | 516 | Q2M2I8 | |
| GQPNKMQTLTQDQSQ | 176 | P51816 | |
| VQLSPGNQQEMKNNV | 71 | Q155Q3 | |
| VQMQVQPQQSNAGVG | 1036 | Q68CP9 | |
| LQQQQMKQQIGSPGQ | 2296 | Q92793 | |
| PQQGQVKLTMAQLTQ | 2266 | Q12830 | |
| EVKPLSGNQGQQMIQ | 491 | Q149M9 | |
| GQEVAIKQMNLQQQP | 306 | O75914 | |
| QSPQHQQQMGQVLQQ | 3471 | Q8NEZ4 | |
| QVQQQKLEQQQRGMG | 546 | Q71SY5 | |
| PLQMKLQQVNGLGQG | 5286 | Q9UPN3 | |
| QQIVPSQGQMVQQQG | 626 | Q14686 | |
| SQGQMVQQQGTLNPQ | 631 | Q14686 | |
| NQMMGPQGQVLLQQN | 696 | Q14686 | |
| INIQPKPIQMGQQNT | 311 | Q6AI39 | |
| NGQNKSCQNILNRMP | 1846 | Q9H799 | |
| RTLPGQNSDMKQQQQ | 346 | Q8TAL5 | |
| MQNQNVPGNIELTVN | 666 | Q13620 | |
| NPSQAGQQQGQQKQK | 91 | Q5XKR4 | |
| QQQQQQNGGQNKVRP | 96 | P32243 | |
| VQGKRTLPGLQQQQQ | 206 | P51531 | |
| QQKQKQQRGQGTMNP | 1121 | Q92540 | |
| LGMQQPAQSQQVTIQ | 796 | Q9Y2K2 | |
| QQQQPALQGVTLQQM | 506 | Q15714 | |
| LQQQQPNDKTNIQGM | 246 | P61371 | |
| LQKVSGNQQIVGQPQ | 951 | Q8IWZ3 | |
| NMQGQVVPTNQIQSG | 596 | O15516 | |
| GGSNSNQQQQMRLQQ | 296 | P46937 | |
| EQAKIPQGTQQGQQQ | 301 | Q9UGU0 | |
| INIQCSTIGQMPNNQ | 391 | Q8NDV7 | |
| QLQLQQRQGSMQIPQ | 311 | Q96PN7 |